{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T06:20:39Z","timestamp":1783405239251,"version":"3.54.6"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Although an insulin-to-C-peptide molar ratio greater than 1 has traditionally been considered suggestive of insulin autoimmune syndrome (IAS), its diagnostic value remains controversial, and the optimal cutoff is unclear. This study aimed to evaluate the diagnostic performance of the insulin-to-C-peptide molar ratio for distinguishing IAS and exogenous insulin antibody syndrome (EIAS) from insulinoma and to identify the optimal diagnostic cutoff.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively collected clinical and biochemical data from 19 patients with IAS, 33 with EIAS, and 70 control patients with pathologically confirmed insulinoma. Receiver-operating-characteristic (ROC) curve analysis was performed separately for IAS versus insulinoma and EIAS versus insulinoma to assess the diagnostic performance of the insulin-to-C-peptide molar ratio in the fasting state and during hypoglycemic episodes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The insulin-to-C-peptide molar ratio was significantly higher in IAS and EIAS than in insulinoma at both fasting and during hypoglycemic episodes. During hypoglycemic episodes, the area under the ROC curve (AUC) was 0.970 for IAS versus insulinoma and 0.944 for EIAS versus insulinoma, with optimal cutoffs of 0.382 and 0.552, respectively. In the fasting state, the corresponding AUCs were 0.916 and 0.961, with optimal cutoffs of 0.309 and 0.386. Compared with the conventionally used cutoff of 1, the optimal cutoffs substantially improved sensitivity while maintaining high specificity, particularly for IAS. Insulin concentration alone also showed good diagnostic performance for distinguishing IAS from insulinoma, with AUCs of 0.985 and 0.943 and optimal cutoffs of 83.1 and 58.86 \u03bcIU\/mL during hypoglycemic episodes and in the fasting state, respectively, but was less informative for EIAS, with AUCs of 0.853 and 0.729 and optimal cutoffs of 67.85 and 71.94 \u03bcIU\/mL, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The insulin-to-C-peptide molar ratio, measured either during hypoglycemic episodes or in the fasting state, showed good diagnostic performance for distinguishing IAS and EIAS from insulinoma. The conventionally used cutoff of 1 appears to be too high, and lower cutoffs may provide better sensitivity while preserving specificity. Validation in larger cohorts is needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1879250","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T05:45:58Z","timestamp":1783403158000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic utility of the insulin-to-C-peptide molar ratio in differentiating insulin autoimmune syndrome and exogenous insulin antibody syndrome from insulinoma"],"prefix":"10.3389","volume":"17","author":[{"given":"Yang","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology of the National Health Commission, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwen","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology of the National Health Commission, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology of the National Health Commission, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baodi","family":"Xing","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology of the National Health Commission, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Ping","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology of the National Health Commission, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology of the National Health Commission, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology of the National Health Commission, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology of the National Health Commission, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huabing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology of the National Health Commission, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology of the National Health Commission, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S219438","article-title":"Insulin autoimmune syndrome (Hirata disease): A comprehensive review fifty years after its first description","volume":"13","author":"Cappellani","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/agm2.70007","article-title":"Insulin autoimmune syndrome: A Chinese expert consensus statement","volume":"8","author":"Zhang","year":"2025","journal-title":"Aging Med (Milton)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1530\/EC-17-0309","article-title":"Exogenous insulin antibody syndrome (EIAS): A clinical syndrome associated with insulin antibodies induced by exogenous insulin in diabetic patients","volume":"7","author":"Hu","year":"2018","journal-title":"Endocr Connect"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14634","article-title":"Comparison of patient characteristics between East Asian and non-East Asian patients with insulin autoimmune syndrome","volume":"96","author":"Oest","year":"2022","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12334","article-title":"Insulin autoimmune syndrome (Hirata disease) in European Caucasians taking \u03b1-lipoic acid","volume":"81","author":"Gullo","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgac578","article-title":"Hypoglycemia caused by exogenous insulin antibody syndrome: A large single-center case series from China","volume":"108","author":"Liu","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1984.00350220067015","article-title":"Insulin autoimmunity as a cause of hypoglycemia","volume":"144","author":"Benson","year":"1984","journal-title":"Arch Intern Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1055\/s-2001-15113","article-title":"Severe hypoglycemia due to insulin autoimmune syndrome with insulin autoantibodies crossreactive to proinsulin","volume":"109","author":"Lohmann","year":"2001","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"B9","doi-asserted-by":"publisher","first-page":"335","DOI":"10.21037\/atm.2018.07.32","article-title":"Insulin autoimmune syndrome: From diagnosis to clinical management","volume":"6","author":"Censi","year":"2018","journal-title":"Ann Transl Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s00125-023-05877-9","article-title":"Islet autoantibody standardization program: Interlaboratory comparison of insulin autoantibody assay performance in 2018 and 2020 workshops","volume":"66","author":"Marzinotto","year":"2023","journal-title":"Diabetologia"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1258\/acb.2008.007262","article-title":"Polyethylene glycol precipitation: Proceed with care","volume":"45","author":"Fahie-Wilson","year":"2008","journal-title":"Ann Clin Biochem"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13179","article-title":"Diagnosis of insulin autoimmune syndrome using polyethylene glycol precipitation and gel filtration chromatography with ex vivo insulin exchange","volume":"86","author":"Church","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-013-2588-9","article-title":"Recurrent hypoglycemia from insulin autoimmune syndrome","volume":"29","author":"Wong","year":"2014","journal-title":"J Gen Intern Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1013645","article-title":"C-peptide to insulin molar ratios at fasting and after oral glucose in 247 healthy subjects","volume":"17","author":"Bonora","year":"1985","journal-title":"Horm Metab Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2019.03.009","article-title":"Insulin autoimmune syndrome diagnosis and therapy in a single Chinese center","volume":"41","author":"Yuan","year":"2019","journal-title":"Clin Ther"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v15.i7.1489","article-title":"Association between glucose-lowering drugs and circulating insulin antibodies induced by insulin therapy in patients with type 2 diabetes","volume":"15","author":"Zhang","year":"2024","journal-title":"World J Diabetes"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2025.112262","article-title":"Clinical, genetic, and proteomic characteristics of type 2 diabetes complicated with exogenous insulin antibody syndrome: A case-control study","volume":"225","author":"Wan","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.906012","article-title":"Case report: Hypoglycemia due to metastatic insulinoma in insulin-dependent type 2 diabetes successfully treated with 177 Lu-DOTATATE","volume":"13","author":"Kumar","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.957369","article-title":"Case report: Insulinoma co-existing with type 2 diabetes - Advantages and challenges of treatment with endoscopic ultrasound-guided radiofrequency ablation","volume":"13","author":"Chang","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2015.07.017","article-title":"Commercial insulin immunoassays fail to detect commonly prescribed insulin analogues","volume":"48","author":"Parfitt","year":"2015","journal-title":"Clin Biochem"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1043301","article-title":"Type 1 diabetes complicated with cyclic vomiting syndrome and exogenous insulin antibody syndrome: A case report","volume":"13","author":"Geng","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2011.01395.x","article-title":"A review of modern insulin analogue pharmacokinetic and pharmacodynamic profiles in type 2 diabetes: Improvements and limitations","volume":"13","author":"Evans","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2015.1058779","article-title":"Comparison of the pharmacokinetic and pharmacodynamic profiles of insulin degludec and insulin glargine","volume":"11","author":"Heise","year":"2015","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1410","article-title":"Evaluation and management of adult hypoglycemic disorders: An Endocrine Society clinical practice guideline","volume":"94","author":"Cryer","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.2337\/dc26-S006","article-title":"6. Glycemic goals, hypoglycemia, and hyperglycemic crises: Standards of care in diabetes-2026","volume":"49","year":"2026","journal-title":"Diabetes Care"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.17925\/EE.2020.16.2.168","article-title":"Insulin autoimmune syndrome \u2013 A case series","volume":"16","author":"Boro","year":"2020","journal-title":"Eur Endocrinol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-00972","article-title":"Assessment and management of anti-insulin autoantibodies in varying presentations of insulin autoimmune syndrome","volume":"103","author":"Church","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B28","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12887-025-05395-0","article-title":"Insulin autoimmune syndrome in a 3-year-old boy: The youngest to date in China and a narrow review","volume":"25","author":"Cheng","year":"2025","journal-title":"BMC Pediatr"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/hvab043","article-title":"Increased C-peptide immunoreactivity in insulin autoimmune syndrome (Hirata disease) due to high molecular weight proinsulin","volume":"67","author":"Kay","year":"2021","journal-title":"Clin Chem"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e34009","article-title":"When discordant insulin and C-peptide levels lead to a medical diagnosis in a patient with transient hypoglycemia: Varying degrees of interference of insulin-antibody complexes on three insulin immunoassays","volume":"10","author":"Teoli","year":"2024","journal-title":"Heliyon"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-56-3-608","article-title":"Reduced hepatic insulin extraction in obesity: Relationship with plasma insulin levels","volume":"56","author":"Rossell","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaf043","article-title":"Utility of the C-peptide\/insulin molar ratio for distinguishing type A insulin resistance syndrome from type 2 diabetes","volume":"110","author":"Nishikage","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"B33","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1530\/EDM-18-0122","article-title":"Spontaneously remitting insulin autoimmune syndrome in a patient taking alpha-lipoic acid","volume":"2018","author":"Cappellani","year":"2018","journal-title":"Endocrinol Diabetes Metab Case Rep"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1879250\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T05:45:59Z","timestamp":1783403159000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1879250\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":33,"alternative-id":["10.3389\/fendo.2026.1879250"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1879250","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"article-number":"1879250"}}